Oral anticoagulation should be managed in the community with  treatment aimed at standard therapeutic targets and increased  recall intervals.
Fitzmaurice
D A
DA
Department of Primary Care, University of Birmingham, Edgbaston, Birmingham, UK. d.a.fitzmaurice@bham.ac.uk
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D003151:Community Health Centers; D019468:Disease Management; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans
D000925:Anticoagulants